2023-2024 EMBRACE MBC Virtual Forum Series
Dana-Farber Cancer Institute
One of the Toughest Parts of Treatment: Managing "Scanxiety"
FEATURING
Jess Mosey
- 1 view
- April 3, 2024
Dana-Farber Cancer Institute
Concepts of Treatment, Progression, and Staging in mBC
FEATURING
Sarah Sammons
- 8 views
- April 2, 2024
Dana-Farber Cancer Institute
Sexual Health and Sexual Recovery for Adults Living With mBC
FEATURING
Sharon Bober
- 13 views
- March 4, 2024
Dana-Farber Cancer Institute
Antibody Drug Conjugates Highlights - mBC Series
FEATURING
Harold Burstein
- 147 views
- February 15, 2024
- 1
Dana-Farber Cancer Institute
Metastatic Disease Survivors - mBC Series
FEATURING
Harold Burstein
- 175 views
- February 15, 2024
- 3
Dana-Farber Cancer Institute
ER+ Disease Highlights - mBC Series
FEATURING
Harold Burstein
- 115 views
- February 15, 2024
- 1
Dana-Farber Cancer Institute
Standard Treatments for HR+/HER2- mBC in 2023
FEATURING
Sarah Sammons
- 848 views
- November 14, 2023
- 5
Dana-Farber Cancer Institute
What’s New in Research for ER+ mBC
FEATURING
Antonio Giordano
- 91 views
- November 14, 2023
- 4
Dana-Farber Cancer Institute
Current Treatment Options for Patients With HER2+ mBC
FEATURING
Nancy Lin
- 276 views
- November 14, 2023
- 2
Dana-Farber Cancer Institute
HER2+ mBC: What’s Coming Up in Research?
FEATURING
Adrienne Waks
- 98 views
- November 14, 2023
- 1
Dana-Farber Cancer Institute
What's New in Treatment for TNBC
FEATURING
Megan Tesch
- 115 views
- November 14, 2023
- 3
Dana-Farber Cancer Institute
What's New in Research for mTNBC
FEATURING
Paolo Tarantino
- 97 views
- November 14, 2023
- 1
Dana-Farber Cancer Institute
Antibody Drug Conjugates in Breast Cancer
FEATURING
Sara Tolaney
- 434 views
- November 14, 2023
- 6
Dana-Farber Cancer Institute
Recent Advances in mBC and Update on the EMBRACE Program
FEATURING
Nancy Lin
- 83 views
- November 14, 2023
- 1